Search results for “T cell receptor binding” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 80 patents, we discovered top 26 key players by total patent application. CERo Therapeutics, Inc., LAVA Therapeutics NV, CEL-SCI Corp. are dominant in this area. They take 50.00% of the total patent filing.
STARTUP
CERo Therapeutics, Inc.
California, United States
Patent: 16
LAVA Therapeutics NV
Utrecht, Netherlands
Patent: 15
CEL-SCI Corp.
Virginia, United States
Patent: 9
Adaptimmune Ltd.
YORK COUNTY, United Kingdom
Patent: 9
Immunocore Ltd.
United Kingdom
Patent: 9
Auckland Uniservices
Australia
Patent: 7
STARTUP
Inscripta, Inc.
Colorado, United States
Patent: 3
Avidex Ltd.
United Kingdom
Patent: 2
Agilent Technologies, Inc.
Beijing Shi, China
Patent: 1
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 19 patents, we discovered top 2 start-ups by total patent application.
STARTUP
CERo Therapeutics, Inc.
California, United States
Patent: 16
STARTUP
Inscripta, Inc.
Colorado, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 32 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing CERo Therapeutics, Inc., LAVA Therapeutics NV, Inscripta, Inc. take 78.13% of patent filing during this period.
STARTUP
CERo Therapeutics, Inc.
California, United States
Patent: 16
LAVA Therapeutics NV
Utrecht, Netherlands
Patent: 6
STARTUP
Inscripta, Inc.
Colorado, United States
Patent: 3
Eutilex Co., Ltd.
South Korea
Patent: 1
Agenus, Inc.
Massachusetts, United States
Patent: 1
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 1
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
Ludwig Institute for Cancer Research Ltd.
New York, United States
Patent: 1
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 32 patents in last 5 years, we discover 7 new entrants. CERo Therapeutics, Inc., Inscripta, Inc., Eutilex Co., Ltd. are the most active new entrants in this area.
STARTUP
CERo Therapeutics, Inc.
California, United States
Patent: 16
STARTUP
Inscripta, Inc.
Colorado, United States
Patent: 3
Eutilex Co., Ltd.
South Korea
Patent: 1
Agenus, Inc.
Massachusetts, United States
Patent: 1
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 1
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
BioNTech Cell & Gene Therapies GmbH
Rheinland-Pfalz, Germany
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 34 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Hirosaki University
Aomori-ken, Japan
Patent: 2
University of Washington
Washington, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: